ALEMBIC PHARMA Surges by 5%; BSE HEALTHCARE Index Up 0.5%
April 26, 2019 11:18 AM

ALEMBIC PHARMA share price has zoomed 5% and is presently trading at Rs 560.

Meanwhile, the BSE HEALTHCARE Index is at 14,594 (up 0.5%).

Among the top Gainers in the BSE HEALTHCARE Index today is ALEMBIC PHARMA (up 5.4%).

GSK PHARMA (down 0.2%) and GRANULES INDIA (down 0.2%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 518 to Rs 560, registering a gain of Rs 42 (up 8.0%).

On the other hand, the BSE HEALTHCARE has moved up from 13,952 to 14,594, registering a gain of 642 points (up 4.0%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were SUVEN LIFESCIENCES (up 51.3%), DIVIS LABORATORIES (up 48.8%) and PFIZER (up 40.7%).

What About the Benchmark Indices?

The BSE Sensex is at 38,898 (up 0.2%).

The top gainers among the BSE Sensex stocks today are TATA STEEL (up 5.9%), AXIS BANK (up 1.4%) and TCS (up 1.3%). Other gainers include INFOSYS (up 1.2%) and NTPC (up 1.1%). The most traded stocks in the BSE Sensex are YES BANK and AXIS BANK.

In the meantime, NSE Nifty is at 11,698 (up 0.3%). TATA STEEL (up 6.2%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 34,501 to 38,898, registering a gain of 4,397 points (up 12.4%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit stood at Rs 2 billion for the quarter ended December 2018, compared to a profit of Rs 1 billion a year ago. Net Sales rose 21.2% to Rs 10.2 billion during the period as against Rs 8.4 billion in October-December 2017.

For the year ended March 2018, ALEMBIC PHARMA reported 3.4% increase in net profit to Rs 4.2 billion compared to net profit of Rs 4.1 billion during FY17.

Revenue of the company grew 0.1% to Rs 31 billion during FY18.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 18.7x.